-
-
-
-
-
-
-
Candel Therapeutics, Inc. (CADL) Misses Q3 EPS by 3c
-
-
-
-
-
-
-
Candel Therapeutics, Inc. (CADL) Reports Q2 Loss of $0.74/sh
-
-
-
-
-
-
-
Candel Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Highlights
-
-
-
-
-
-
-
Candel Therapeutics Reports First Quarter 2022 Financial Results and Recent Corporate Highlights
-
-
-
-
-
-
1,222,848 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

